OrthoPediatrics Corp. Announces Distribution Agreement with Thrive Orthopedics LLC
Rhea-AI Summary
OrthoPediatrics Corp. (NASDAQ: KIDS) has announced a distribution agreement with Thrive Orthopedics through its OrthoPediatrics Specialty Bracing (OPSB) division. The agreement covers three pediatric orthotic solutions:
1. The F3 Hero Pediatric AFO: A carbon fiber ankle foot orthosis for children with walking challenges due to cerebral palsy, spina bifida, or chemotherapy-related foot drop.
2. The TruStretch Pediatric Equinus Brace®: An above-the-knee brace for stretching gastroc-soleus muscles in children with equinus deformity.
3. The Thrive® Pediatric X-Glide Carbon Fiber Insoles: Available in rigid and flexible styles as lightweight gait training tools.
Positive
- Expansion of product portfolio through distribution rights for three new pediatric orthotic solutions
- Strategic growth in non-operative care segment
Negative
- None.
Insights
The distribution agreement with Thrive Orthopedics marks a strategic expansion in OrthoPediatrics' non-operative care segment, particularly noteworthy in the growing pediatric orthotics market. The addition of three specialized products - the carbon fiber AFO, equinus brace and insoles - addresses specific unmet needs in pediatric mobility disorders.
The technological differentiation is particularly compelling - the lightweight carbon fiber construction in the F3 Hero AFO represents a significant advancement over traditional plastic AFOs, potentially offering better compliance and outcomes for conditions like cerebral palsy and chemotherapy-induced foot drop. The TruStretch brace's above-knee design for equinus deformity suggests improved biomechanical advantage.
From a market perspective, this agreement strengthens OrthoPediatrics' competitive position in the non-operative care segment, which typically offers higher margins and recurring revenue opportunities compared to surgical solutions. The focus on specialized pediatric applications aligns with healthcare's shift toward conservative treatment options where possible, potentially reducing the need for surgical intervention in some cases.
While specific financial terms weren't disclosed, the distribution model allows OrthoPediatrics to expand its product portfolio without significant R&D investment, suggesting an efficient use of capital. The agreement could accelerate market penetration through OrthoPediatrics' established distribution network while providing complementary solutions to their existing product line.
WARSAW, Ind., Jan. 22, 2025 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, announced today that the Company gained distribution rights to bring additional bracing solutions to the US market through its OrthoPediatrics Specialty Bracing (OPSB) division.
OrthoPediatrics’ OPSB division has established a distribution agreement with Thrive Orthopedics LLC focused on three unique pediatric orthotic solutions. The Thrive Orthopedics F3 Hero Pediatric AFO is a lightweight carbon fiber ankle foot orthosis that provides the stability needed to improve walking while allowing flexibility and energy return at the correct moments to produce a more normalized, smooth, and dynamic walking pattern. This type of AFO is indicated for children who have challenges walking due to cerebral palsy, spina bifida, foot drop due to chemotherapy, or many other diagnoses. The TruStretch Pediatric Equinus Brace® is an innovative “above the knee” bracing solution that provides optimal stretching of the gastroc-soleus muscles for children with equinus deformity. The Thrive® Pediatric X-Glide Carbon Fiber Insoles come in both rigid and flexible foot plate styles and offer low profile and lightweight gait training tools.
Joe Hauser, OrthoPediatrics Specialty Bracing division President, commented, “The OPSB team is starting the new year off with exciting news. I am so proud of everything we are advancing to help more KIDS with non-operative care. The distribution agreement with Thrive Orthopedics represents the next phase of our planned growth, bringing more innovative solutions to children around the world.”
About OrthoPediatrics Corp.
Founded in 2006, OrthoPediatrics is an orthopedic company focused exclusively on advancing the field of pediatric orthopedics. As such it has developed the most comprehensive product offering to the pediatric orthopedic market to improve the lives of children with orthopedic conditions. OrthoPediatrics currently markets over 70 products that serve three of the largest categories within the pediatric orthopedic market. This product offering spans trauma and deformity, scoliosis, and sports medicine/other procedures. OrthoPediatrics’ global sales organization is focused exclusively on pediatric orthopedics and distributes its products in the United States and over 70 countries outside the United States. For more information, please visit www.orthopediatrics.com. For more information about the OrthoPediatrics Specialty Bracing portfolio, please visit https://opsb.com/.
About Thrive Orthopedics
Thrive Orthopedics was founded on one simple premise; to help practitioners and patients by designing and delivering the best carbon fiber AFOs in the world. We believe our products have the best function, craftsmanship, value, and warranty in the entire industry. We are delivering health with compassion and care.
Investor Contact
Philip Trip Taylor
Gilmartin Group
philip@gilmartinir.com
415-937-5406
FAQ
What products are included in OrthoPediatrics' (KIDS) distribution agreement with Thrive Orthopedics?
What conditions can be treated with the F3 Hero Pediatric AFO from OrthoPediatrics (KIDS)?
What is the purpose of the TruStretch Pediatric Equinus Brace® in OrthoPediatrics' (KIDS) new product line?
How does the F3 Hero Pediatric AFO from OrthoPediatrics (KIDS) improve patient mobility?
